KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Total Debt (2016 - 2025)

Historic Total Debt for Halozyme Therapeutics (HALO) over the last 14 years, with Q4 2025 value amounting to $2.1 billion.

  • Halozyme Therapeutics' Total Debt rose 4229.2% to $2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 billion, marking a year-over-year increase of 4229.2%. This contributed to the annual value of $2.1 billion for FY2025, which is 4229.2% up from last year.
  • Per Halozyme Therapeutics' latest filing, its Total Debt stood at $2.1 billion for Q4 2025, which was up 4229.2% from $1.5 billion recorded in Q3 2025.
  • In the past 5 years, Halozyme Therapeutics' Total Debt ranged from a high of $2.1 billion in Q4 2025 and a low of $89.0 million during Q1 2021
  • In the last 5 years, Halozyme Therapeutics' Total Debt had a median value of $1.5 billion in 2023 and averaged $1.2 billion.
  • As far as peak fluctuations go, Halozyme Therapeutics' Total Debt skyrocketed by 301444.56% in 2021, and later crashed by 45.53% in 2023.
  • Over the past 5 years, Halozyme Therapeutics' Total Debt (Quarter) stood at $876.7 million in 2021, then skyrocketed by 71.8% to $1.5 billion in 2022, then dropped by 0.45% to $1.5 billion in 2023, then rose by 0.44% to $1.5 billion in 2024, then surged by 42.29% to $2.1 billion in 2025.
  • Its Total Debt stands at $2.1 billion for Q4 2025, versus $1.5 billion for Q3 2025 and $1.5 billion for Q2 2025.